|
|
|
|
|
|
Sponsors and Collaborators: |
University of California, San Francisco University of Utah Massachusetts General Hospital University of Puerto Rico Aga Khan University University of South Africa Universidad del Turabo Texas A&M University |
Information provided by: | University of California, San Francisco |
ClinicalTrials.gov Identifier: | NCT00241202 |
The goals of this research are: 1) To test the efficacy of a self-care symptom management manual by examining whether people who use the manual find it to be useful; 2) To examine symptom and demographic data related to self-care behaviors, symptom control, medication adherence and enhanced quality of life.
The University of California, San Francisco is the coordinating site for this multi-site international study.
Condition | Intervention |
HIV Acquired Immunodeficiency Syndrome |
Behavioral: Symptom Management Manual |
MedlinePlus related topics: | AIDS Palliative Care |
Study Type: | Interventional |
Study Design: | Other, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | The Efficacy of the HIV/AIDS Symptom Management Manual |
Enrollment: | 775 |
Study Start Date: | October 2005 |
Study Completion Date: | December 2006 |
Primary Completion Date: | December 2006 (Final data collection date for primary outcome measure) |
People living with HIV/AIDS encounter many psychological, physiological, and cognitive symptoms, such as pain, diarrhea, fever, fatigue, depression, and confusion. These symptoms have been found to restrict a person's daily life significantly. Self-management of multiple HIV and medication side effects symptoms and maintaining optimal quality of life have, therefore, become major daily tasks for people living with HIV/AIDS.
This study is a randomized controlled trial with a two-group repeated measures design to test the efficacy of the symptom management manual. Two groups (experimental and control) will be assessed in a repeated measures design at 3 time points: baseline (time 0), one month (time 1), and two months (time 2). Data will be analyzed using longitudinal mixture modeling.
Comparison(s): HIV-positive patients receiving a symptom management manual and orientation to the manual, compared to HIV-positive patients receiving a nutrition manual and orientation to the manual.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |||||
San Francisco Veteran's Affairs Medical Center | |||||
San Francisco, California, United States, 94121 | |||||
PositiveHealth Practice | |||||
San Francisco, California, United States, 94143-0378 | |||||
United States, Illinois | |||||
Jackson Park Hospital | |||||
Chicago, Illinois, United States, 60649 | |||||
United States, Massachusetts | |||||
Boston Living Center | |||||
Boston, Massachusetts, United States, 02116 | |||||
United States, Texas | |||||
Valley AIDS Clinic - Harlingen | |||||
Harlingen, Texas, United States, 78550 | |||||
Thomas Street Health Center | |||||
Houston, Texas, United States, 77009 | |||||
United States, Utah | |||||
University of Utah Health Science Center | |||||
Salt Lake City, Utah, United States, 84112 | |||||
Kenya | |||||
Nazareth Hospital | |||||
Nairobi, Kenya | |||||
Puerto Rico | |||||
AIDS Clinical Trials Unit | |||||
San Juan, Puerto Rico, 00936 | |||||
Casita de Salud Integral Ramón Vicente, Universidad del Turabo | |||||
Vega Baja, Puerto Rico, 00693 | |||||
South Africa | |||||
PAH ARV Clinic - Tshwane District Hospital | |||||
Pretoria, South Africa, 0001 |
University of California, San Francisco |
University of Utah |
Massachusetts General Hospital |
University of Puerto Rico |
Aga Khan University |
University of South Africa |
Universidad del Turabo |
Texas A&M University |
Principal Investigator: | William L. Holzemer, RN, PhD | University of California, San Francisco |
Sponsor's website 
  |
Responsible Party: | University of California, San Francisco ( William L. Holzemer ) |
Study ID Numbers: | H642-27289 |
First Received: | October 13, 2005 |
Last Updated: | January 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00241202 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|
|